Skip to main content

Table 3 Clinical characteristics of pediatric patients treated by CD19 CAR T cells [20,21,22]

From: CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?

  1. CMAS Childhood Myositis Assessment Scale, CAT -BM Cutaneous Assessment Tool (CAT) in the shortened Binary Method version (CAT-BM), CK Creatine kinase, GC Glucocorticoids, HCQ Hydroxychloroquine, MMF Mycophenolate mofetil, MTX Methotrexate, CYC Cyclophosphamide
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us